Hadassah

Student with MS Running the Jerusalem Marathon to Support Hadassah’s MS Program

Wednesday, Feb 14 2018

Dov Guggenheim at Hadassah

Thanks to his physicians at the Hadassah Medical Center, Dov Guggenheim, who was diagnosed with Multiple Sclerosis (MS) in 2015, has gone from “depressed to optimistic, paralyzed to athletic, and, most important, hopeless to hopeful.”

In appreciation for this drastic improvement in his quality of life, he is running the Jerusalem Marathon to raise money for Hadassah’s MS program.

With trust in his doctors and faith in the rapidly developing research into medical treatments for MS,  Dov has been able to keep a positive outlook. Together with others at Hadassah’s MS Center, he established the MS running team last year and registered for the March 2017 Jerusalem Marathon. The team members dedicated themselves to raising money and awareness for the groundbreaking research being done by Hadassah in developing a stem cell cure for MS (and hopefully ALS as well).

Dov ran in the 2017 marathon with one leg barely functioning because of another MS attack, and “celebrated” back in the Emergency Room. That, however, was his last attack to date.

In June 2017, he was hospitalized once again. This time for treatment with a relatively new MS drug that has had good results in preventing attacks and even reducing brain and spine lesions. He will have to repeat the in-hospital treatment in another few months. But he has been lucky enough to regain control of his life during the past year.

He now has brought together another dedicated running team to raise money for Hadassah research with this breakthrough treatment. If all goes well, he may no longer need this treatment, but thousands of MS and ALS sufferers may benefit.

“Perhaps by next year, or the year after,” Dov says, “we will run in celebration, because the cure will have been found.”

Read more of Dov’s story in his blog.

Learn more about the Hadassah Medical Organization.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Tuesday, Apr 17 2018

Where are we with Stem Cells? Hadassah Pioneer Brings Us Up to Date

Many diseases involve the malfunctioning or dying of cells within the body.

READ MORE ›
alt_text

Tuesday, Apr 17 2018

Predicting Clinical Outcomes for Multiple Sclerosis Patients: Cutting-Edge Research at Hadassah

More than two million people--two to three times more women--have multiple sclerosis (MS)--the leading cause of neurological disability among young adults. What is their prognosis?

READ MORE ›
alt_text

Friday, Apr 13 2018

Hadassah Hospital Mount Scopus Hosts Conference to Mark Annual World Down Syndrome Day

Hadassah Hospital Mount Scopus hosted 200 people at the annual World Down Syndrome Day conference, held at the hospital in late March.

READ MORE ›
alt_text

Friday, Apr 13 2018

Hadassah Physicians Increase Number of Partial Thyroidectomies Following New ATA Guidelines

Following updated recommendations from the American Thyroid Association (ATA), Nir Hirschoren, M.D., of the Hadassah-Hebrew University Medical Center in Jerusalem...

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More